Allelic Ratio of KRAS Mutations in Pancreatic Cancer

Oncologist - United States
doi 10.1634/theoncologist.2014-0408
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

KRAS Mutations in Blood Circulating Cell-Free DNA: A Pancreatic Cancer Case-Control

Oncotarget
Oncology
2016English

Pancreatic Cancer: Circulating Tumor Cells and Primary Tumors Show Heterogeneous KRAS Mutations

Scientific Reports
Multidisciplinary
2017English

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

PLoS ONE
Multidisciplinary
2014English

Germline Mutations in Pancreatic Cancer Become Better Defined

CA - A Cancer Journal for Clinicians
OncologyHematology
2016English

Germline Mutations in Japanese Familial Pancreatic Cancer Patients

Oncotarget
Oncology
2016English

P1.13-45 Coexistence of Activating BRAF and KRAS Mutations in Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2015English

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Nature
Multidisciplinary
2012English

KRAS Codon 12 and 13 Mutations in Gastric Cancer in the Northeast Iran

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy